Seeking Alpha
13 Nov 2026, 16:52 UTC · 1h ago
Utah Medical Products: A $25 Million Buyback Isn't Enough
Impact · against what's priced in
UTMD is a hold as the modest benefits of a share buyback and a small acquisition are offset by persistent core revenue declines. The 12.1% drop in Q3 revenue outweighs the net income growth, which was largely driven by non-operational expense reductions.
- UTMD−0.20
No priced-in read yet
- In context
The 12.1% decline in Q3 revenue suggests ongoing core business weakness that is not fully mitigated by a $25 million buyback or the acquisition of Orion Medical Supplies.
Read from the article alone
Search tags
